Correlation between vascular endothelial growth factor-C expression and invasion phenotype in cervical carcinomas

被引:61
作者
Ueda, M
Terai, Y
Yamashita, Y
Kumagai, K
Ueki, K
Yamaguchi, H
Akise, D
Hung, YC
Ueki, M
机构
[1] Osaka Med Coll, Dept Obstet & Gynecol, Osaka 5698686, Japan
[2] China Med Coll, Dept Obstet & Gynecol, Taichung, Taiwan
关键词
VEGF-C; MMP; invasion; angiogenesis; cervical carcinoma;
D O I
10.1002/ijc.10193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The correlation between vascular endothelial growth factor (VEGF)-C gene expression and in vitro invasive activity and matrix metalloproteinase (MMP)-2 or 9 gene expression and proteolytic activity in 11 cervical carcinoma cell lines, was investigated. Immunohistochemical expression of VEGF-C in 52 cervical carcinoma tissues was also correlated with tumor aggressiveness with respect to clinicopathologic features, tumor vascularity, MMP-2 expression and patient outcome. Expression of VEGF-C mRNA differed remarkably among the cell lines and there was a statistical correlation between VEGF-C gene expression and the number of invaded tumor cells (p = 0.0009) and MMP-2 gene expression and activity (p < 0.05). Anti-VEGF-C antibody inhibited the invasive and proteolytic activity of tumor cells in a concentration-dependent manner. VEGF-C or MMP-2 expression in clinical tissue samples was well correlated with depth of myometrial invasion, endometrial invasion, pelvic lymphnode metastasis and tumor vascularity (p < 0.05) and there was a close relation between VEGF-C and MMP-2 expression (p < 0.0001) in cervical carcinomas. Overall survival rates for 14 patients with strong VEGF-C staining tumors were lower than those for 38 patients with weak VEGF-C staining tumors (P = 0.0132) and VEGF-C tissue status emerged as an independent prognostic parameter (p = 0.0232). These results suggest that VEGF-C expression is closely related to invasion phenotype and affects the patient's survival in cervical carcinomas. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:335 / 343
页数:9
相关论文
共 49 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]  
ALBINI A, 1987, CANCER RES, V47, P3239
[3]  
[Anonymous], ACTA OBST GYNAEC JPN
[4]   Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features [J].
Bunone, G ;
Vigneri, P ;
Mariani, L ;
Butó, S ;
Collini, P ;
Pilotti, S ;
Pierotti, MA ;
Bongarzone, I .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1967-1976
[5]   VASCULAR-PERMEABILITY FACTOR - A UNIQUE REGULATOR OF BLOOD-VESSEL FUNCTION [J].
CONNOLLY, DT .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1991, 47 (03) :219-223
[6]   THE IMPLICATIONS OF ANGIOGENESIS FOR THE BIOLOGY AND THERAPY OF CANCER METASTASIS [J].
FIDLER, IJ ;
ELLIS, LM .
CELL, 1994, 79 (02) :185-188
[7]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[8]   ANGIOGENIC FACTOR [J].
FURUKAWA, T ;
YOSHIMURA, A ;
SUMIZAWA, T ;
HARAGUCHI, M ;
AKIYAMA, S ;
FUKUI, K ;
ISHIZAWA, M ;
YAMADA, Y .
NATURE, 1992, 356 (6371) :668-668
[9]   ANGIOGENIC ACTIVITY OF ENZYMES [J].
HARAGUCHI, M ;
MIYADERA, K ;
UEMURA, K ;
SUMIZAWA, T ;
FURUKAWA, T ;
YAMADA, K ;
AKIYAMA, S ;
YAMADA, Y .
NATURE, 1994, 368 (6468) :198-198
[10]   ELECTROPHORETIC ANALYSIS OF PLASMINOGEN ACTIVATORS IN POLYACRYLAMIDE GELS CONTAINING SODIUM DODECYL-SULFATE AND COPOLYMERIZED SUBSTRATES [J].
HEUSSEN, C ;
DOWDLE, EB .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) :196-202